Abeona Therapeutics (ABEO) Operating Income (2016 - 2025)
Historic Operating Income for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$24.0 million.
- Abeona Therapeutics' Operating Income fell 5652.0% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.2 million, marking a year-over-year decrease of 3697.41%. This contributed to the annual value of -$64.2 million for FY2024, which is 3622.79% down from last year.
- As of Q3 2025, Abeona Therapeutics' Operating Income stood at -$24.0 million, which was down 5652.0% from -$22.8 million recorded in Q2 2025.
- Abeona Therapeutics' 5-year Operating Income high stood at -$8.0 million for Q2 2022, and its period low was -$46.7 million during Q4 2021.
- Its 5-year average for Operating Income is -$16.8 million, with a median of -$14.6 million in 2021.
- In the last 5 years, Abeona Therapeutics' Operating Income plummeted by 22218.23% in 2021 and then soared by 7227.13% in 2022.
- Quarter analysis of 5 years shows Abeona Therapeutics' Operating Income stood at -$46.7 million in 2021, then skyrocketed by 72.27% to -$12.9 million in 2022, then fell by 2.11% to -$13.2 million in 2023, then fell by 26.22% to -$16.7 million in 2024, then crashed by 44.06% to -$24.0 million in 2025.
- Its last three reported values are -$24.0 million in Q3 2025, -$22.8 million for Q2 2025, and -$19.7 million during Q1 2025.